Impact of time interval and dose rate on cell survival following low-dose fractionated exposures. 2017

Shingo Terashima, and Yoichiro Hosokawa, and Eichi Tsuruga, and Yasushi Mariya, and Toshiya Nakamura
Department of Radiation Science, Hirosaki University Graduate School of Health Sciences, 66-1 Hon-cho, Hirosaki, Aomori 036-8564, Japan.

Enhanced cell lethality, also known as hyper-radiosensitivity, has been reported at low doses of radiation (≤0.5 Gy) in various cell lines, and is expected to be an effective cancer therapy. We conducted this study to examine the impact of time interval and dose rate of low-dose fractionated exposures with a short time interval. We evaluated the cell-survival rates of V79 and A549 cells using clonogenic assays. We performed fractionated exposures in unit doses of 0.25, 0.5, 1.0 and 2.0 Gy. We exposed the cells to 2 Gy of X-rays (i) at dose-rates of 1.0, 1.5 and 2.0 Gy/min at 1-min intervals and (ii) at a dose-rate of 2.0 Gy/min at 10-s, 1-min and 3-min intervals by fractionated exposures. Apoptosis and cell cycle analyses were also evaluated in the fractionated exposures (unit dose 0.25 Gy) and compared with single exposures by using flow cytometry. Both cell-type survival rates with fractionated exposures (unit dose 0.25 Gy) with short time intervals were markedly lower than those for single exposures delivering the same dose. When the dose rates were lower, the cytotoxic effect decreased compared with exposure to a dose-rate of 2.0 Gy/min. On the other hand, levels of apoptosis and cell cycle distribution were not significantly different between low-dose fractionated exposures and single exposures in either cell line. These results indicate that a stronger cytotoxic effect was induced with low-dose fractionated exposures with a short time interval for a given dose due to the hyper-radiosensitivity phenomenon, suggesting that dose rates are important for effective low-dose fractionated exposures.

UI MeSH Term Description Entries
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D019583 Dose Fractionation, Radiation Administration of the total dose of radiation (RADIATION DOSAGE) in parts, at timed intervals. Radiotherapy Dose Fractionation,Dose Fractionation, Radiotherapy,Radiation Dose Fractionation,Dose Fractionations, Radiotherapy,Fractionation, Radiation Dose,Fractionation, Radiotherapy Dose,Fractionations, Radiotherapy Dose,Radiotherapy Dose Fractionations

Related Publications

Shingo Terashima, and Yoichiro Hosokawa, and Eichi Tsuruga, and Yasushi Mariya, and Toshiya Nakamura
November 2002, International journal of radiation biology,
Shingo Terashima, and Yoichiro Hosokawa, and Eichi Tsuruga, and Yasushi Mariya, and Toshiya Nakamura
March 2012, Physics in medicine and biology,
Shingo Terashima, and Yoichiro Hosokawa, and Eichi Tsuruga, and Yasushi Mariya, and Toshiya Nakamura
February 1960, Radiation research,
Shingo Terashima, and Yoichiro Hosokawa, and Eichi Tsuruga, and Yasushi Mariya, and Toshiya Nakamura
December 1991, The British journal of radiology,
Shingo Terashima, and Yoichiro Hosokawa, and Eichi Tsuruga, and Yasushi Mariya, and Toshiya Nakamura
September 1967, Radiation research,
Shingo Terashima, and Yoichiro Hosokawa, and Eichi Tsuruga, and Yasushi Mariya, and Toshiya Nakamura
May 1988, International journal of radiation oncology, biology, physics,
Shingo Terashima, and Yoichiro Hosokawa, and Eichi Tsuruga, and Yasushi Mariya, and Toshiya Nakamura
January 1978, International journal of radiation oncology, biology, physics,
Shingo Terashima, and Yoichiro Hosokawa, and Eichi Tsuruga, and Yasushi Mariya, and Toshiya Nakamura
September 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Shingo Terashima, and Yoichiro Hosokawa, and Eichi Tsuruga, and Yasushi Mariya, and Toshiya Nakamura
January 1990, International journal of radiation biology,
Shingo Terashima, and Yoichiro Hosokawa, and Eichi Tsuruga, and Yasushi Mariya, and Toshiya Nakamura
January 1996, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!